Rocket Pharmaceuticals (RCKT)
(Delayed Data from NSDQ)
$18.59 USD
+0.10 (0.54%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $18.58 -0.01 (-0.05%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth D Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/04/2024
Time: -- |
9/2024 | $-0.77 | -2.24% |
Earnings Summary
For their last quarter, Rocket Pharmaceuticals (RCKT) reported earnings of -$0.74 per share, in line with the Zacks Consensus Estimate. This reflects a breakeven earnings surprise. Look out for RCKT's next earnings release expected on November 04, 2024. For the next earning release, we expect the company to report earnings of -$0.77 per share, reflecting a year-over-year decrease of 2.67%.
Earnings History
Price & Consensus
Zacks News for RCKT
FDA Rejects Rocket's (RCKT) Gene Therapy BLA for Rare Disease
RCKT: What are Zacks experts saying now?
Zacks Private Portfolio Services